host
cell
possess
metabol
asset
requir
viral
infect
recent
studi
indic
control
host
metabol
resourc
core
hostpathogen
interact
virus
evolv
mechan
usurp
host
metabol
resourc
funnel
toward
product
virion
compon
well
organ
special
compart
replic
matur
dissemin
consequ
host
develop
varieti
metabol
countermeasur
sens
resist
viral
chang
complex
interplay
viru
host
metabol
control
begun
deconvolut
howev
clear
viral
induc
metabol
reprogram
substanti
impact
infecti
outcom
highlight
promis
target
process
antivir
therapeut
develop
progeni
addit
provid
energi
biomass
necessari
turn
cell
product
viru
factori
new
metabol
contribut
infect
emerg
includ
small
molecul
enzymat
activ
organ
viral
matur
compart
synthes
special
virion
compon
regul
immunolog
environ
figur
virallyinduc
metabol
chang
go
unnot
host
rather
repres
major
hostpathogen
interact
sway
infecti
outcom
collect
recent
find
made
clear
landscap
metabolicallytarget
therapeut
intervent
expand
wide
varieti
virus
activ
glycolysi
drive
product
energi
form
atp
nadh
nadph
figur
activ
glycolysi
also
suppli
carbon
necessari
synthesi
numer
core
biomolecul
includ
nucleotid
lipid
amino
acid
carbohydr
figur
number
dna
virus
induc
glycolysi
includ
kaposi
sarcomaassoci
herpesviru
kshv
hcmv
adenoviru
human
papillomaviru
hpv
epsteinbarr
viru
ebv
multipl
rna
virus
also
activ
glycolyt
flux
includ
dengu
hepat
c
hcv
influenza
although
notabl
except
herp
simplex
vaccinia
viru
number
evolutionari
divers
virus
target
glycolysi
speak
broad
import
pathway
viral
infect
recent
specif
viral
mechan
target
glycolysi
begun
elucid
instanc
hcv
protein
shown
bind
activ
hexos
kinas
rate
control
glycolyt
enzym
kshv
employ
specif
viral
microrna
target
known
regul
glucos
metabol
mitochondri
biogenesi
induc
glycolyt
activ
hcmv
shown
induc
activ
ampactiv
kinas
ampk
regul
numer
glycolyt
activ
hcmvmediat
activ
ampk
found
necessari
glycolyt
activ
high
titer
infect
hcmv
also
shown
induc
proglycolyt
transcript
program
activ
host
transcript
factor
chrebp
induc
express
numer
glycolyt
enzym
import
virallymedi
activ
glycolysi
glycolyt
carbon
enter
tricarboxyl
acid
tca
cycl
reaction
provid
addit
energi
well
metabol
precursor
feed
biosynthesi
amino
acid
fatti
acid
figur
mani
virus
activ
glycolysi
also
induc
increas
concentr
tca
cycl
compon
infect
hcmv
activ
tca
cycl
glycolysi
simultan
use
glycolyt
carbon
feed
tca
cycl
ultim
produc
fatti
acid
import
infect
similarli
hcmv
vaccinia
viru
induc
increas
glutamin
catabol
hcmv
vaccinia
depend
increas
glutamin
catabol
high
titer
infect
figur
contrast
substanti
impact
glycolysi
induc
pyruv
carboxyl
anaplerot
replenish
tca
cycl
metabolit
divert
tca
intermedi
toward
pyrimidin
biosynthesi
comparison
glycolysi
less
known
variou
viral
infect
impact
specif
tca
cycl
metabol
flux
measur
tca
cycl
metabol
activ
difficult
due
number
metabol
flux
flow
cycl
addit
mani
tca
intermedi
compartment
cytoplasm
mitochondri
pool
complic
metabol
inquiri
mitochondri
physiolog
play
import
role
tca
cycl
function
cover
detail
number
virus
implic
target
mitochondri
dynam
review
state
kshv
encod
target
microrna
neg
impact
mitochondri
biogenesi
activ
potenti
interact
heat
shock
protein
hbv
hcv
promot
mitochondri
fission
mitophagi
dynaminrel
protein
downregul
apoptosi
may
enhanc
viral
persist
hcmv
u
l
protein
also
disrupt
reticular
mitochondri
network
block
mitochondri
apoptot
signal
mani
activ
antiapoptot
clear
provir
consequ
would
also
predict
substanti
effect
mitochondri
metabol
includ
tca
cycl
activ
cellular
energet
like
also
import
viral
infect
howev
larg
unclear
viral
protein
target
mitochondria
dynam
impact
core
mitochondri
metabol
function
tcacyclederiv
citrat
transport
mitochondria
suppli
carbon
fatti
acid
biosynthesi
ultim
support
lipid
biosynthesi
figur
number
dna
virus
includ
hcmv
vaccinia
induc
lipid
biosynthesi
necessari
high
titer
infect
hcmv
activ
pathway
part
induc
express
activ
acetylcoa
carboxylas
rate
control
enzym
fatti
acid
biosynthesi
inhibit
fatti
acid
synthas
fasn
attenu
hcmv
replic
late
stage
infect
without
impact
viral
protein
accumul
late
time
defect
consist
role
fatti
acid
biosynthesi
viral
assembl
envelop
hcmv
infect
induct
fatti
acid
biosynthet
enzym
mediat
viral
activ
sterol
regulatori
element
bind
protein
srebp
transcript
factor
control
express
fatti
acid
metabol
gene
vaccinia
infect
also
sensit
fasn
inhibit
pharmacolog
inhibit
either
acc
fasn
strongli
reduc
viral
titer
inhibit
virion
envelop
manner
could
partial
rescu
addit
exogen
palmit
key
product
fatti
acid
biosynthesi
variou
rna
virus
also
target
fatti
acid
biosynthesi
mani
studi
implic
import
lipid
metabol
hcv
infect
summar
detail
follow
review
rotaviru
rv
replic
also
shown
suscept
inhibitor
target
variou
lipid
synthet
enzym
studi
context
dengu
viru
infect
show
viral
nonstructur
protein
preferenti
recruit
activ
fasn
site
viral
replic
de
novo
fatti
acid
biosynthesi
format
lipid
droplet
found
promot
tombusviru
rhinoviru
replic
addit
target
fatti
acid
biosynthesi
virus
found
target
revers
catabol
process
fatti
acid
oxid
hcmv
japanes
enceph
viru
jev
inhibit
fatti
acid
oxid
target
mitochondri
trifunct
protein
mtp
catalyz
fatti
acid
oxid
jev
inhibit
mtp
protein
hcmv
redirect
cellular
viperin
protein
inhibit
mtp
contrast
virus
inhibit
fatti
acid
oxid
hcv
infect
requir
fatti
acid
oxid
replic
highlight
certain
aspect
viral
metabol
manipul
viru
specif
combin
data
indic
virallymedi
manipul
lipid
metabol
broadli
import
viral
infect
virus
evolv
divers
mechan
ensur
hostcel
lipid
metabol
machineri
coopt
support
viral
infect
indic
number
virus
induc
reli
host
cell
lipid
metabol
mani
case
exact
contribut
specif
lipid
metabol
enzym
make
toward
viral
infect
unclear
howev
certain
theme
emerg
increasingli
appear
virus
target
hostcel
lipid
modifi
enzym
mean
organ
viral
assembl
matur
compart
figur
theme
readili
appar
recent
work
replic
complex
form
plusstrand
rna
virus
dengu
viru
hcv
rhinoviru
remodel
endoplasm
reticulum
er
gener
site
replic
use
mechan
reli
host
lipid
biosynthesi
dengu
viru
protein
specif
recruit
fatti
acid
synthas
viral
replic
site
critic
dengu
replic
hcv
phosphatidylinositol
iii
alpha
import
host
factor
format
replic
compart
hcv
stimul
activ
like
interact
hcv
induc
accumul
phosphatidylinositol
er
allow
product
replic
similarli
rhinoviru
replic
requir
redistribut
cholesterol
er
golgi
membran
despit
similar
lipid
requir
relat
virus
respect
erderiv
replic
compart
uniqu
conform
size
investig
may
reveal
virusspecif
lipid
requir
drive
format
structur
may
therapeut
exploit
modul
hostcel
lipid
metabol
activ
also
appear
import
virion
assembl
hcv
reli
triglycerid
tag
cholesterol
ester
biosynthesi
viral
assembl
pharmaceut
inhibit
pathway
impair
process
subsequ
reduc
viru
infect
tag
mediat
interact
hcv
nucleocapsid
protein
lipid
droplet
play
critic
role
stabil
hcv
nucleocapsid
phosphatidylserin
core
phospholipid
membran
constitu
also
implic
import
viral
infect
ebola
particl
preferenti
incorpor
phosphatidylserinerich
membran
envelop
enteroviru
infect
special
phosphatidylserinerich
vesicl
facilit
mass
transmiss
multipl
genom
uninfect
cell
appar
virallymedi
alter
lipid
modifi
metabol
activ
shape
lipid
compart
emerg
import
compon
divers
viral
life
cycl
author
manuscript
author
manuscript
author
manuscript
becom
increasingli
evid
addit
simpli
elev
product
molecular
precursor
support
infect
virus
target
specif
metabol
activ
individu
tailor
special
virion
compon
figur
exampl
hcmv
infect
induc
express
fatti
acid
elongas
increas
concentr
satur
verylongchain
fatti
acid
vlcfa
vlcfa
concentr
envelop
hcmv
virion
pharmaceut
inhibit
rnaimedi
knockdown
longchain
acylcoa
synthetas
fatti
acid
elongas
key
enzym
biosynthesi
vlcfa
attenu
hcmv
replic
exact
contribut
vlfca
make
toward
viral
replic
unclear
like
specif
biophys
properti
vlcfa
contribut
aspect
virion
matur
stabil
transmiss
regardless
find
viral
infect
select
induc
specif
hostcel
metabol
activ
import
infect
rais
possibl
activ
would
make
attract
target
therapeut
intervent
addit
tailor
fatti
acid
metabol
activ
viral
envelop
virus
target
small
molecul
metabol
activ
posttransl
modifi
viral
protein
modif
divers
includ
fatti
acidbas
modif
myristoyl
palmitoyl
myrist
modif
hiv
gag
play
crucial
role
gag
bind
plasma
membran
integr
step
allow
hiv
enter
cell
myristoyl
virion
protein
also
import
hcmv
infect
addit
myristoyl
group
tegument
protein
requir
product
replic
shown
crucial
proper
local
function
anoth
fatti
acidbas
protein
modif
palmitoyl
shown
import
influenza
coronaviru
hcv
replic
particip
process
rang
protein
traffick
virion
assembl
infect
mani
virus
also
depend
protein
glycosyl
glycosyl
dengu
viral
protein
import
viral
genom
replic
mutat
abolish
glycosyl
site
decreas
dengu
rna
replic
product
infecti
virion
hbv
infect
depend
specif
glycosyl
envelop
protein
infect
hsv
hcmv
reli
specif
glycosyl
envelop
glycoprotein
hcmv
recent
found
increas
biosynthesi
variou
udpsugar
molecular
subunit
suppli
glycosyl
reaction
funnel
increas
pyrimidin
biosynthesi
toward
udpsugar
biosynthesi
inhibit
de
novo
pyrimidin
biosynthesi
attenu
envelop
protein
glycosyl
deplet
udpsugar
pool
infectionspecif
manner
reduc
viral
titer
protein
glycosyl
modif
vari
complex
clear
viral
protein
glycosyl
target
critic
viral
infect
numer
question
remain
specif
glycosyl
pattern
contribut
viru
infect
whether
specif
udpglycosyl
transferas
recruit
modif
viral
protein
grow
bodi
literatur
indic
viral
infect
modul
small
molecul
metabol
modul
inflamm
immun
function
exampl
divers
virus
includ
hcv
hcmv
west
nile
viru
observ
target
sphingolipid
metabol
sphingolipid
divers
famili
bioactiv
lipid
speci
play
role
varieti
immun
process
lymphocyt
migrat
mast
cell
regul
apoptot
control
review
level
bioactiv
sphingolipid
ceramid
induc
earli
time
point
hcmv
life
cycl
found
import
infect
hcv
infect
also
induc
express
sphingomyelin
synthas
increas
sphingolipid
synthesi
block
attenu
infect
sphingolipid
repres
nexu
point
cellular
immunolog
process
individu
small
molecul
particip
varieti
contextdepend
signal
event
induct
sphingolipid
pool
viral
infect
potenti
aid
infect
varieti
way
enhanc
cell
prolifer
surviv
provid
lipid
compon
replic
compart
prostaglandin
anoth
famili
bioactiv
lipid
variou
immunomodulatori
signal
activ
famili
prostaglandin
divers
effect
viral
infect
shown
context
depend
either
proor
antivir
effect
observ
depend
prostaglandin
specif
viru
studi
prostaglandin
shown
inhibit
number
viral
famili
includ
poxvirus
herpesvirus
retrovirus
howev
hcmv
induc
express
ratelimit
biosynthet
enzym
prostaglandin
biosynthesi
induct
activ
increas
level
prostaglandin
import
hightit
infect
primat
cytomegalovirus
acquir
gene
host
viral
express
homolog
import
viral
replic
specif
context
influenza
viru
also
upregul
infect
lead
inhibit
interferon
product
decreas
antigen
present
tcellmedi
immun
clear
bioactiv
lipid
metabol
signal
impact
viral
infect
divers
way
specif
contribut
viral
infect
host
immun
emerg
normal
cell
exhibit
specif
metabol
program
base
parent
tissu
function
role
within
organ
given
import
metabol
network
infect
follow
viral
tropism
could
shape
underli
tissuespecif
metabol
differ
tropic
differ
display
retroviru
famili
member
present
one
exampl
retrovirus
capabl
replic
divid
cell
wherea
lentivirus
capabl
replic
nondivid
cell
macrophag
level
dntp
major
metabol
distinct
quiescent
nondivid
cell
macrophag
rapidli
divid
cell
macrophag
exhibit
fold
reduc
concentr
dntp
precursor
rel
cell
compar
biochem
analysi
revers
transcriptas
rt
express
versu
varieti
retrovirus
unabl
replic
macrophag
demonstr
rt
much
higher
dntp
bind
affin
nonmacrophagetrop
retrovirus
elev
dntp
bind
found
function
import
macrophag
tropism
mutant
possess
rt
reduc
retrovir
enzymat
kinet
unabl
replic
macrophag
retain
abil
replic
divid
cell
comprehens
review
retrovir
tropism
nucleotid
pool
found
broaden
understand
host
cell
metabol
contribut
viral
infect
impact
tissuespecif
metabol
differ
abil
virus
grow
differ
cell
type
like
becom
increasingli
appar
virus
target
mani
aspect
hostcel
metabol
regul
activ
clear
host
evolv
mechan
maintain
metabol
control
upon
infect
one
restrict
factor
limit
lentiviru
infect
variou
myeloid
dendrit
lineag
triphosphohydrolas
control
dntp
pool
size
dephosphoryl
activ
prevent
util
lentivir
revers
transcriptas
lentivirus
evolv
mechan
block
activ
vpx
accessori
protein
encod
vpx
bind
inhibit
result
increas
dntp
concentr
restor
viral
replic
variou
sirtuin
famili
member
also
found
broad
antivir
effect
sirtuin
evolutionarili
conserv
naddepend
enzym
whose
famili
member
enzymat
regul
number
protein
posttransl
modif
includ
adpribosyl
acetyl
acyl
review
class
sirtuin
major
metabol
regul
upon
activ
typic
inhibit
metabol
pathway
induc
viral
infect
includ
glycolysi
fatti
acid
biosynthesi
specif
antivir
effect
variou
sirtuin
famili
member
requir
studi
revers
common
virallyinduc
metabol
phenotyp
known
import
infect
like
contribut
sirtuin
famili
antivir
effect
mention
prostaglandin
long
known
immunomodulatori
activ
new
studi
continu
identifi
novel
way
small
moleculebas
signal
contribut
immun
one
exampl
discoveri
interferoninduc
enzym
produc
oxysterol
regul
immun
respons
increas
activ
disrupt
hcv
genom
replic
interf
srebp
lipid
biosynthet
transcript
factor
attenu
host
lipid
synthesi
exampl
small
molecul
immunoregulatori
activ
includ
recent
find
intracellular
metabolit
signal
immun
cell
upon
extracellular
releas
eg
apoptosi
necrosi
releas
extracellular
nucleotid
serv
findm
signal
recruit
monocyt
macrophag
exampl
strongli
argu
intracellular
extracellular
small
molecul
environ
shape
immun
howev
field
still
earli
stage
mani
question
remain
specif
mechan
involv
see
outstand
question
number
virallyinduc
metabol
chang
mention
mirror
metabol
chang
occur
oncogenesi
despit
aris
divers
tissu
type
cancer
cell
display
rel
similar
metabol
program
includ
activ
glycolysi
induct
nucleotid
biosynthesi
activ
fatti
acid
biosynthesi
mani
virus
includ
hbv
hpv
hcv
kshv
play
direct
causal
role
human
tumorigenesi
induc
variou
metabol
activ
contribut
metabol
chang
make
toward
oncogenesi
regardless
infecti
etiolog
becom
major
focu
cancer
biolog
research
review
extent
share
metabol
phenotyp
associ
oncogenesi
viral
infect
like
reflect
common
prolif
goal
cancer
cell
virus
ie
creation
larg
amount
energi
biomass
product
progeni
howev
common
metabol
phenotyp
infect
cell
cancerderiv
cell
line
also
present
challeng
studi
viral
infect
occur
predomin
context
cancerderiv
cell
line
given
metabol
similar
perhap
unsurpris
transform
cell
line
produc
higher
viral
titer
rel
nontransform
tissu
howev
studi
viral
replic
cell
viral
metabol
phenotyp
becom
difficult
discern
underli
metabol
contribut
associ
oncogenesi
import
contribut
specif
viral
factor
respons
drive
viral
metabol
reprogram
would
like
miss
studi
cancercel
background
alreadi
exhibit
metabol
chang
physiolog
relev
system
contribut
made
factor
would
evid
could
studi
eye
toward
therapeut
intervent
avoid
complic
ideal
analysi
viral
metabol
modul
occur
physiolog
relev
system
possibl
therebi
move
away
studi
sole
transform
cell
clear
virus
evolv
mechan
target
host
cell
metabol
ensur
persist
virus
usurp
host
small
molecul
resourc
provid
energi
molecular
build
block
support
infect
virus
also
target
small
molecul
metabol
organ
viral
matur
compart
modul
immun
respons
host
howev
passiv
bystand
respect
viral
metabol
manipul
rather
host
respond
variou
level
includ
innat
mechan
limit
viral
metabol
modul
individu
infect
cell
well
metabol
immunosurveil
immun
system
control
small
molecul
network
continu
emerg
core
hostpathogen
interact
determin
outcom
viral
infect
make
worthwhil
goal
target
viralhost
metabol
regul
mean
limit
viral
infect
achiev
goal
aid
number
factor
first
continu
elucid
small
molecul
metabol
activ
import
viral
infect
well
mechan
contribut
infect
broaden
number
candid
therapeut
target
success
therapeut
develop
requir
suffici
wide
therapeut
window
limit
viral
replic
without
induc
toxic
target
virallyencod
metabol
activ
success
clinic
strategi
eg
variou
nucleotid
analog
howev
viral
enzym
quickli
evolv
resist
target
therapeut
necessit
cocktailtyp
therapi
increas
concern
toxic
target
hostcel
metabol
activ
would
larg
limit
abil
virus
evolutionarili
acquir
resist
target
host
enzym
also
rais
concern
potenti
toxic
concern
mind
virallyinduc
host
lipid
metabol
activ
appear
particularli
attract
candid
therapeut
target
number
inhibitor
type
alreadi
fda
approv
wide
prescrib
cholesterollow
statin
conclus
initi
stage
understand
mechan
virushost
metabol
interplay
contribut
infecti
outcom
howev
import
mechan
viral
infect
immun
continu
emerg
therefor
area
appear
increasingli
fertil
develop
novel
therapeut
strategi
product
infecti
virion
requir
energi
biomolecular
build
block
deriv
host
cell
metabol
network
divers
set
host
metabol
activ
drive
mass
product
viral
nucleic
acid
red
structur
protein
black
octagon
nonstructur
protein
phospholipid
envelop
black
circl
glycosyl
protein
white
circl
addit
organ
viral
matur
compart
increasingli
found
depend
lipid
modifi
enzym
viral
infect
also
found
induc
specif
metabol
activ
form
special
virion
compon
import
infect
lastli
evid
support
import
small
molecul
metabol
immun
regul
increas
find
process
target
viral
infect
